Bristol-Myers Squibb   3Q Revenues: $4.1 billion (+9%)   3Q Earnings: $692 million (loss of $713 million 3Q12) YTD Revenues: $11.9 billion (-11%) YTD Earnings: $1.8 billion (+17%) Comments: U.S. sales increased 1% to $2.0 billion in the quarter. International sales were up 19% to $2.0 billion. Yervoy sales were up 33% to $238 million. Onglyza/Kombiglyze sales were up 19% to $211 million. Sprycel sales grew 20% to $316 million. Orencia sales grew 22% to $375 million. Baraclude sales were $378...